98%
921
2 minutes
20
• Integration of POCUS findings in the clinical context is crucial. • Valvular abnormalities may not be identified by POCUS. • Valvular disease should not be excluded based solely on a POCUS. • Careful review of POCUS studies in real time may help mitigate some POCUS pitfalls.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399537 | PMC |
http://dx.doi.org/10.1016/j.case.2022.05.002 | DOI Listing |
J Cardiovasc Electrophysiol
April 2025
Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Background: The epidemiological landscape and treatment efficacy of atrial fibrillation (AF) in the Middle East, notably in the United Arab Emirates (UAE), remain under-explored, presenting a distinct demographic and clinical pattern compared to Western populations. The FLOW-AF Registry aimed to bridge this knowledge gap by examining the characteristics, treatment patterns, clinical outcomes, and healthcare resource utilization (HCRU) of newly diagnosed non-valvular atrial fibrillation (NVAF) patients in the UAE, contributing to the scant literature on NVAF management in the region.
Methods: This multicenter, prospective observational study enrolled patients diagnosed with NVAF across six sites in the UAE.
Oncologist
July 2023
Ascension Texas Cardiovascular, Cedar Park, TX, USA.
Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually develop CaHD; these patients face a significantly increased risk of morbidity and mortality. Guidance papers (eg, clinical practice guidelines, consensus guidelines, and expert statements) have been established by major organizations across the disciplines of cardiology and oncology; however, these recommendations are not routinely implemented.
View Article and Find Full Text PDFFront Cardiovasc Med
January 2023
Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Background: Carcinoid heart disease (CnHD) is a frequent cause of morbidity and mortality in patients with neuroendocrine tumors and carcinoid syndrome. Although valve replacement surgery appears to decrease all-cause mortality in patients with advanced CnHD, few studies have investigated the outcomes of patients after valve replacement.
Methods: We conducted a multi-institution retrospective registry of patients who received both tricuspid and pulmonic bioprosthetic valve (TV/PV) replacements for advanced CnHD from November 2005 to March 2021.
J Vasc Surg
December 2022
Department of Surgery, Rijnstate, Arnhem, The Netherlands.
Objective: There is a significant cardiac morbidity and mortality after endovascular aneurysm repair (EVAR). However, information about long-term risk of cardiac events after EVAR and potential predictors is lacking. Therefore, the aim of this study was to determine incidence and predictors of major adverse cardiac events (MACE) at 1 and 5 years after elective EVAR for infrarenal abdominal aortic aneurysms.
View Article and Find Full Text PDFCochrane Database Syst Rev
September 2021
Cochrane Vascular, University of Edinburgh, Edinburgh, UK.
Background: Chronic deep venous insufficiency is caused by incompetent vein valves, blockage of large-calibre leg veins, or both; and causes a range of symptoms including recurrent ulcers, pain and swelling. Most surgeons accept that well-fitted graduated compression stockings (GCS) and local care of wounds serve as adequate treatment for most people, but sometimes symptoms are not controlled and ulcers recur frequently, or they do not heal despite compliance with conservative measures. In these situations, in the presence of severe venous dysfunction, surgery has been advocated by some vascular surgeons.
View Article and Find Full Text PDF